Joshua Riggs
Vermogen: 238 247 $ op 31-05-2026
Vermogen: 238 247 $ op 31-05-2026
Mr. Joshua Riggs is a President, Chief Executive Officer & Director at Insight Molecular Diagnostics, Inc. He is on the Board of Directors at Insight Molecular Diagnostics, Inc. Mr. Riggs was previously employed as a Principal by Bethesda Group LLC and a Principal by Intelliger Consulting LLC.
He received his undergraduate degree from Adelphi University and an MBA from the University of Mississippi.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 27-04-2026 | 38.365 ( 0,13% ) | 238 247 $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| INSIGHT MOLECULAR DIAGNOSTICS INC. | Algemeen Directeur | 01-12-2022 |
| Bedrijven | Functie | Einde |
|---|---|---|
Bethesda Group LLC | Corporate Officer/Principal | 01-07-2020 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 4 |
|---|---|
Adelphi University
Adelphi University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Mississippi
University of Mississippi Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
OncoCyte Corp.
OncoCyte Corp. BiotechnologyHealth Technology Focuses on the discovery, development and commercialization of novel, non-invasive, liquid biopsy diagnostics for the early detection of cancer | Health Technology |
Bethesda Group LLC |
Kies jouw editie
Alle financiële informatie op nationaal niveau